Pfizer Inc. (JOBS) Rheumatoid Arthritis Drug Effective in Study

NEW YORK, Oct 25 (Reuters) - Pfizer Inc's experimental pill for rheumatoid arthritis appeared to be effective and well-tolerated in a mid-stage clinical study, the drugmaker said.
MORE ON THIS TOPIC